S

Surgical Science Sweden AB
STO:SUS

Watchlist Manager
Surgical Science Sweden AB
STO:SUS
Watchlist
Price: 127 SEK -1.17%
Market Cap: 6.5B SEK
Have any thoughts about
Surgical Science Sweden AB?
Write Note

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
Surgical Science Sweden AB

Revenue
838.2m SEK
Cost of Revenue
-264m SEK
Gross Profit
574.3m SEK
Operating Expenses
-426.5m SEK
Operating Income
147.8m SEK
Other Expenses
50m SEK
Net Income
197.7m SEK

Margins Comparison
Surgical Science Sweden AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
Surgical Science Sweden AB
STO:SUS
6.6B SEK
69%
18%
24%
US
Abbott Laboratories
NYSE:ABT
204.7B USD
56%
17%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD
67%
26%
29%
US
Stryker Corp
NYSE:SYK
139.9B USD
64%
22%
16%
US
Boston Scientific Corp
NYSE:BSX
124.8B USD
69%
18%
11%
IE
Medtronic PLC
NYSE:MDT
114.5B USD
66%
19%
12%
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD
45%
15%
7%
DE
Siemens Healthineers AG
XETRA:SHL
53.5B EUR
38%
12%
8%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
339.1B CNY
65%
37%
34%
US
Edwards Lifesciences Corp
NYSE:EW
40B USD
79%
28%
74%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD
41%
13%
9%
Country SE
Market Cap 6.6B SEK
Gross Margin
69%
Operating Margin
18%
Net Margin
24%
Country US
Market Cap 204.7B USD
Gross Margin
56%
Operating Margin
17%
Net Margin
14%
Country US
Market Cap 180.7B USD
Gross Margin
67%
Operating Margin
26%
Net Margin
29%
Country US
Market Cap 139.9B USD
Gross Margin
64%
Operating Margin
22%
Net Margin
16%
Country US
Market Cap 124.8B USD
Gross Margin
69%
Operating Margin
18%
Net Margin
11%
Country IE
Market Cap 114.5B USD
Gross Margin
66%
Operating Margin
19%
Net Margin
12%
Country US
Market Cap 67.7B USD
Gross Margin
45%
Operating Margin
15%
Net Margin
7%
Country DE
Market Cap 53.5B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country CN
Market Cap 339.1B CNY
Gross Margin
65%
Operating Margin
37%
Net Margin
34%
Country US
Market Cap 40B USD
Gross Margin
79%
Operating Margin
28%
Net Margin
74%
Country US
Market Cap 39.7B USD
Gross Margin
41%
Operating Margin
13%
Net Margin
9%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
Surgical Science Sweden AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
Surgical Science Sweden AB
STO:SUS
6.6B SEK
4%
4%
3%
3%
US
Abbott Laboratories
NYSE:ABT
204.7B USD
15%
8%
12%
10%
US
Intuitive Surgical Inc
NASDAQ:ISRG
180.7B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
139.9B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
124.8B USD
9%
5%
9%
7%
IE
Medtronic PLC
NYSE:MDT
114.5B USD
8%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
67.7B USD
5%
3%
6%
6%
DE
Siemens Healthineers AG
XETRA:SHL
53.5B EUR
11%
4%
8%
5%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
339.1B CNY
35%
23%
32%
40%
US
Edwards Lifesciences Corp
NYSE:EW
40B USD
59%
43%
19%
20%
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
39.7B USD
22%
5%
10%
7%
Country SE
Market Cap 6.6B SEK
ROE
4%
ROA
4%
ROCE
3%
ROIC
3%
Country US
Market Cap 204.7B USD
ROE
15%
ROA
8%
ROCE
12%
ROIC
10%
Country US
Market Cap 180.7B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 139.9B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 124.8B USD
ROE
9%
ROA
5%
ROCE
9%
ROIC
7%
Country IE
Market Cap 114.5B USD
ROE
8%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 67.7B USD
ROE
5%
ROA
3%
ROCE
6%
ROIC
6%
Country DE
Market Cap 53.5B EUR
ROE
11%
ROA
4%
ROCE
8%
ROIC
5%
Country CN
Market Cap 339.1B CNY
ROE
35%
ROA
23%
ROCE
32%
ROIC
40%
Country US
Market Cap 40B USD
ROE
59%
ROA
43%
ROCE
19%
ROIC
20%
Country US
Market Cap 39.7B USD
ROE
22%
ROA
5%
ROCE
10%
ROIC
7%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More
Back to Top